| Trends in Pharmacological Sciences 1991 |
| Title | Subject | Authors |
|---|
| A physiological role for PAF in the stimulation of mammalian embryonic development. (platelet-activating factor) | Pharmaceuticals and cosmetics industries | O'Neill, Chris |
| Biophysical and genetic analysis of the ligand-binding site of the beta-adrenoceptor. | Pharmaceuticals and cosmetics industries | Dixon, Richard A.F., Strader, Catherine D., Tota, Michael R., Candelore, MariaLuisa Rios |
| ChemIntosh II. (Software Review) (Evaluation) | Pharmaceuticals and cosmetics industries | Chaplin, Martin |
| Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics. (5-hydroxytryptamine) | Pharmaceuticals and cosmetics industries | Beranek, Paul, Bunce, Keith, Tyers, Michael |
| Cloning and structure-function of the H2 histamine receptor. | Pharmaceuticals and cosmetics industries | Birdsall, Nigel J.M. |
| Cloning of a 'D3' receptor subtype expands dopamine receptor family. | Pharmaceuticals and cosmetics industries | Sibley, David R. |
| Cysteine sulphinic acid as a candidate endogenous EAA ligand. (excitatory amino acids) | Pharmaceuticals and cosmetics industries | Griffiths, Roger, Dunlop, John |
| D1/D2 dopamine receptor interaction at the biochemical level. | Pharmaceuticals and cosmetics industries | Strange, Philip G. |
| Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. (includes related article) | Pharmaceuticals and cosmetics industries | Nicholson, C. David, Challiss, R.A. John, Shahid, Mohammed |
| Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed. | Pharmaceuticals and cosmetics industries | Webb, David J. |
| FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. (five-lipoxygenase-activating protein) | Pharmaceuticals and cosmetics industries | Ford-Hutchinson, Anthony W. |
| Function and pharmacology of multiple GABA(sub A) receptor subunits. (gamma-aminobutyric acid) | Pharmaceuticals and cosmetics industries | Wisden, William, Luddens, Hartmut |
| GABA(sub A) receptor phosphorylation: multiple sites, actions and artifacts. (gamma-aminobutyric acid) | Pharmaceuticals and cosmetics industries | Leidenheimer, Nancy J., Browning, Michael D., Harris, R. Adron |
| How we describe competitive antagonists: three questions of usage. | Pharmaceuticals and cosmetics industries | Jenkinson, Donald H. |
| Immunotherapy of human immunodeficiency virus infection. | Pharmaceuticals and cosmetics industries | Hadden, John W. |
| Interethnic variation of drug metabolism. | Pharmaceuticals and cosmetics industries | Kalow, Werner |
| Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. | Pharmaceuticals and cosmetics industries | Radomski, Marek W., Palmer, Richard M.J., Moncada, Salvador |
| Molecular characterization of alpha1- and alpha2-adrenoceptors. (includes related article) (Cover Story) | Pharmaceuticals and cosmetics industries | Lynch, Kevin R., Harrison, Jeffrey K., Pearson, William R. |
| Nonpeptide angiotensin II receptor antagonists. (includes related article) | Pharmaceuticals and cosmetics industries | Timmermans, Pieter B.M.W.M., Wong, Pancras C., Chiu, Andrew T., Herblin, William F. |
| Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. (Cover Story) | Pharmaceuticals and cosmetics industries | Connolly, John (American bishop), Deneris, Evan S., Rogers, Scott W., Duvoisin, Robert |
| Physiological basis of multicompartmental models of drug distribution. (includes related article) | Pharmaceuticals and cosmetics industries | Atkinson, Arthur J., Jr., Tsuen Ih Ruo, Frederiksen, Marilynn C. |
| Progress in the development of potent bombesin receptor antagonists. | Pharmaceuticals and cosmetics industries | Jensen, Robert T., Coy, David H. |
| Receptor classification using antagonists without determining pA2 values. | Pharmaceuticals and cosmetics industries | Kromer, Wolfgang |
| Receptor-gated ion channels may be selective CNS targets for ethanol. (central nervous system) | Pharmaceuticals and cosmetics industries | Gonzales, Rueben A., Hoffman, Paula L. |
| Responses to NMDA receptor antagonists altered by epileptogenesis. (methyl aspartate)(response to J. Willets, R.L. Balster and J.D. Leander, Trends in Pharmacological Sciences, vol. 11, p. 423, 1990) | Pharmaceuticals and cosmetics industries | Loscher, Wolfgang, Honack, Dagmar |
| Seeking a role for the clinical pharmacologist. | Pharmaceuticals and cosmetics industries | Vallance, Patrick |
| The chronically infected cell as a target for the treatment of HIV infection and AIDS. | Pharmaceuticals and cosmetics industries | Lambert, Dennis M., Metcalf, Brian W., Petteway, Stephen R., Jr. |
| The expanding family of guanylyl cyclases. | Pharmaceuticals and cosmetics industries | Garbers, David L., Schulz, Stephanie, Yuen, Peter S.T. |
| The role of neuropeptide Y in cardiovascular regulation. | Pharmaceuticals and cosmetics industries | Waeber, Bernard, Walker, Philippe, Grouzmann, Eric, Burnier, Michel |
| This and that: the fire of Galileo's imagination and putting teeth into toxicology. (adapting the life of Giordano Bruno into pharmacological practice)(includes related article) | Pharmaceuticals and cosmetics industries | Max, B. |
| Uniform distribution of CSA undermines neurotransmitter role. (L-cysteine sulphinic acid) | Pharmaceuticals and cosmetics industries | Evans, Richard H., Kilpatrick, Ian C., Waller, Sarah J. |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
